FI970696A - Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi - Google Patents

Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi Download PDF

Info

Publication number
FI970696A
FI970696A FI970696A FI970696A FI970696A FI 970696 A FI970696 A FI 970696A FI 970696 A FI970696 A FI 970696A FI 970696 A FI970696 A FI 970696A FI 970696 A FI970696 A FI 970696A
Authority
FI
Finland
Prior art keywords
compositions
methods
ribonucleic acids
oligonucleotide conjugates
degrading
Prior art date
Application number
FI970696A
Other languages
English (en)
Swedish (sv)
Other versions
FI970696A0 (fi
Inventor
Dieter Huesken
Heinz Moser
Robert Haener
Jonathan Hall
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI970696A0 publication Critical patent/FI970696A0/fi
Publication of FI970696A publication Critical patent/FI970696A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI970696A 1994-09-02 1997-02-19 Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi FI970696A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH269494 1994-09-02
PCT/EP1995/003408 WO1996007667A1 (de) 1994-09-02 1995-08-30 Oligonukleotidkonjugate, zusammensetzungen und verfahren zur spaltung von ribonukleinsäuren

Publications (2)

Publication Number Publication Date
FI970696A0 FI970696A0 (fi) 1997-02-19
FI970696A true FI970696A (fi) 1997-02-19

Family

ID=4239485

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970696A FI970696A (fi) 1994-09-02 1997-02-19 Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi

Country Status (8)

Country Link
EP (1) EP0778845A1 (fi)
JP (1) JPH10505353A (fi)
AU (1) AU3519095A (fi)
CA (1) CA2197785A1 (fi)
FI (1) FI970696A (fi)
HU (1) HUT77034A (fi)
NO (1) NO970885L (fi)
WO (1) WO1996007667A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798491A (en) * 1993-06-09 1998-08-25 Board Of Regents, The University Of Texas System Multi-mechanistic chemical cleavage using certain metal complexes
US5714328A (en) * 1995-06-07 1998-02-03 Board Of Regents, The University Of Texas System RNA photocleavage using texaphyrins
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
EP0920439B1 (en) * 1996-08-20 2003-04-02 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
KR101040700B1 (ko) * 2006-11-16 2011-06-10 주식회사 엘지화학 테레프탈알데히드의 정제방법
PA8775801A1 (es) 2007-04-06 2009-05-15 Neurocrine Biosciences Inc Antagonista del receptor de la hormona liberadora de gonadotropina y procedimientos relacionados con los mismos
CL2008000986A1 (es) 2007-04-06 2008-10-17 Neurocrine Biosciences Inc COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis

Also Published As

Publication number Publication date
CA2197785A1 (en) 1996-03-14
NO970885L (no) 1997-04-25
JPH10505353A (ja) 1998-05-26
WO1996007667A1 (de) 1996-03-14
AU3519095A (en) 1996-03-27
EP0778845A1 (de) 1997-06-18
FI970696A0 (fi) 1997-02-19
HUT77034A (hu) 1998-03-02
NO970885D0 (no) 1997-02-27

Similar Documents

Publication Publication Date Title
AU2206800A (en) Targeted molecular bar codes and methods for using the same
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
DE69840172D1 (de) Rna exportelement
HK1031374A1 (en) Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives.
NL300150I2 (nl) 4 "-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
NO995925D0 (no) Farmasöytiske sammensetninger omfattende cyklodekstriner
AU4683099A (en) Targeted oligonucleotide conjugates
DE69503126T2 (de) Repetitive oligonukleotide matrix
AU6876698A (en) File with sanitizing agent & method
AU2215995A (en) Freeze-dried compositions comprising rna
PT1042449E (pt) Microorganismo, processo para obtencao do mesmo e aditivo para forragem
FI103704B1 (fi) Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
ATE268758T1 (de) Hypolipidämische propanolaminderivate
EE200000657A (et) Asoolid, nende valmistamismeetod, kasutamine ravimina ja farmatseutiline kompositsioon
FI972548A0 (fi) Oligonukleotidi-dendrimeerikonjugaatit
FI970696A (fi) Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi
EE04398B1 (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
IL137162A0 (en) 2,3,4,5-tetrahydro -1h- [1,4]-benzodiazepine -3- hydroxamic acids as matrix metalloproteinase inhibitors
FI933507A (fi) Bisyklopolyatsamakrosyklofosfonihappoja, niiden komplekseja ja konjugaatteja käytettäväksi varjoaineina ja menetelmä niiden valmistamiseksi
HK1038363A1 (en) Phosphinous and phosphonic acid derivatives used as medicaments.
IT246279Y1 (it) Guarnitura per mobili
FI933506A (fi) Bisyklopolyatsamakrosyklokarboksyylihappokomplekseja, niiden konjugaatteja, menetelmä niiden valmistamiseksi ja käyttö varjoaineina
AU5377599A (en) Nucleic acids
ZA967817B (en) Phenylacetic acids, their preparation, and compositions comprising them.